Administrative Core
行政核心
基本信息
- 批准号:10931064
- 负责人:
- 金额:$ 17.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdministratorAdvocateAwardBioinformaticsBiometryCancer CenterCancer Center Support GrantCaringCell TherapyClinicClinicalClinical TrialsCollaborationsCommunicationComplexConsultationsDataDecision MakingDevelopmentDoctor of MedicineElectronic MailEligibility DeterminationEnsureFox Chase Cancer CenterGrantInfrastructureInstitutionInterdisciplinary StudyLaboratoriesLeadershipMinorityMonitorNational Cancer InstituteOrganOutcomePathologyPatientsPoliciesPreparationPrognosisProgress ReportsProtocols documentationPublicationsQuality ControlRegulationReportingReproduction sporesResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch Project GrantsSiteStem cell transplantStrategic PlanningSupervisionTexasTissuesTranslational ResearchUnited States National Institutes of HealthUniversitiesUniversity of Texas M D Anderson Cancer CenterWomanWorkcareerdata managementdata sharingdesignexperienceimprovedinterdisciplinary collaborationlecturesleukemiameetingsnovelprogramsquality assurancerecruitscreeningsuccesssymposiumtransplantation therapyweb site
项目摘要
PROJECT SUMMARY (ADMINISTRATIVE CORE)
The Administrative Core provides essential support to the MD Anderson Cancer Center and Temple/Fox
Chase Cancer Center Leukemia SPORE PIs and investigators to maximize success. It is co-directed by Drs.
Hagop Kantarjian and Jean-Pierre Issa, who co-chair the Executive Committee and provide overall supervision
of five Projects, two additional Cores, Developmental Research (DRP) and Career Enhancement (CEP)
Programs, and scientific direction of the SPORE. The Core co-Directors rely on the extensive broad-based
scientific, research, and SPORE experience of the Internal and External Advisory Boards in critical decision-
making. Success of the complex interdisciplinary research in the SPORE depends on integration of diverse
leukemia research approaches. The Core will overcome barriers to interdisciplinary collaboration and data
sharing and will ensure a unified translational research effort. The SPORE is founded on planning, integration,
and translational research efforts supported by this Core. Its leadership and staff will be responsible for
monitoring/planning scientific activities; providing scientific direction; ensuring emphasis on translational
research; ensuring interdisciplinary and inter-SPORE integration with major leukemia programs within/outside
MD Anderson and other broad translational research activities; and providing optimal administrative and fiscal
management. Specific responsibilities of the Administrative Core are: Oversee and monitor all SPORE
activities; promote integration and communication among the SPORE-related clinical programs; monitor the
scientific integrity of all research projects, and grant awards; assure compliance with institutional,
governmental, and National Cancer Institute regulations; oversee the fiscal and budgetary activities of the
SPORE; coordinate data control quality assurance issues in conjunction with the Internal Advisory Board and
the Biostatistics, Data Management, and Bioinformatics Core (Core 3); coordinate activities associated with
clinical trials, including design of protocols, approval by regulatory bodies, implementation, and eligibility
screening and assignment of patients to different studies; provide oversight and support for Core 3 and the
Pathology and Tissue Core (Core 2); coordinate and manage meetings of the SPORE Executive Committee,
the Internal and External Advisory Boards, monthly investigator meetings, quarterly research meetings,
lectures, and symposia; administer the DRP and the CEP; coordinate interdisciplinary and inter-SPORE
interactions and exchanges/meetings with other Leukemia SPORE programs and investigators, and other
organ-site SPORE programs; administer the activities of the Patient Advocates; comply with, and improve
policies addressing recruitment and retention of women and minorities; organize seminars to bring to MD
Anderson consultants and speakers with expertise in various clinical and laboratory aspects of leukemia
research; maintain a Leukemia SPORE website focused on issues in leukemia translational research.
项目概要(行政核心)
行政核心为MD安德森癌症中心和Temple/Fox提供必要的支持
大通癌症中心白血病孢子PI和研究人员,以最大限度地提高成功。它是由博士共同指导。
Hagop Kantarjian和Jean-Pierre Issa,他们共同主持执行委员会并提供全面监督
五个项目,两个额外的核心,发展研究(DRP)和职业提升(CEP)
计划和科学方向的孢子。核心共同主任依靠广泛的基础设施,
内部和外部咨询委员会在关键决策方面的科学、研究和SPORE经验-
制作。在SPORE复杂的跨学科研究的成功取决于不同的整合
白血病研究方法。核心将克服跨学科合作和数据的障碍
共享,并将确保统一的翻译研究工作。SPORE是建立在规划,整合,
以及该核心支持的转化研究工作。其领导层和工作人员将负责
监测/规划科学活动;提供科学指导;确保重视转化
研究;确保跨学科和跨孢子整合与主要白血病项目内/外
MD安德森和其他广泛的转化研究活动;并提供最佳的行政和财政
管理行政核心的具体职责是:监督和监测所有SPORE
活动;促进SPORE相关临床项目之间的整合和沟通;监测
所有研究项目的科学完整性,并授予奖项;确保遵守机构,
政府和国家癌症研究所的规定;监督财政和预算活动的
与内部咨询委员会一起协调数据控制质量保证问题,
生物统计学、数据管理和生物信息学核心(核心3);协调与
临床试验,包括方案设计、监管机构批准、实施和合格性
筛选并将患者分配到不同的研究中;为核心3和
病理学和组织核心(核心2);协调和管理SPORE执行委员会的会议,
内部和外部咨询委员会,每月研究者会议,季度研究会议,
讲座和研讨会;管理DRP和CEP;协调跨学科和跨SPORE
与其他白血病孢子项目和研究者的互动和交流/会议,以及其他
器官部位SPORE计划;管理患者倡导者的活动;遵守并改善
解决招聘和保留妇女和少数民族的政策;组织研讨会,
安德森顾问和发言人在白血病的各种临床和实验室方面的专业知识
研究;维护一个白血病孢子网站,专注于白血病转化研究的问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marina Y Konopleva其他文献
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3-Mutated AML
阿扎胞苷、维奈托克和 Gilteritinib 治疗新诊断和复发或难治性 FLT3 突变 AML
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:45.3
- 作者:
N. Short;N. Daver;C. Dinardo;T. Kadia;L. Nasr;W. Macaron;M. Yilmaz;G. Borthakur;G. Montalban;G. Garcia;G. Issa;K. Chien;E. Jabbour;Cedric Nasnas;Xuelin Huang;W. Qiao;J. Matthews;Christopher J Stojanik;K. Patel;R. Abramova;J. Thankachan;Marina Y Konopleva;H. Kantarjian;F. Ravandi - 通讯作者:
F. Ravandi
Marina Y Konopleva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marina Y Konopleva', 18)}}的其他基金
Defining the novel cancer testis antigen HSPA1L as immunotherapeutic target in AML
将新型癌症睾丸抗原 HSPA1L 定义为 AML 的免疫治疗靶点
- 批准号:
10625516 - 财政年份:2022
- 资助金额:
$ 17.74万 - 项目类别:
Defining the novel cancer testis antigen HSPA1L as immunotherapeutic target in AML
将新型癌症睾丸抗原 HSPA1L 定义为 AML 的免疫治疗靶点
- 批准号:
10433726 - 财政年份:2022
- 资助金额:
$ 17.74万 - 项目类别:
Inhibition of Bcl-xL by Targeted Degradation
通过靶向降解抑制 Bcl-xL
- 批准号:
10737840 - 财政年份:2020
- 资助金额:
$ 17.74万 - 项目类别:
Chaperone-Mediated Protein Degradation of Bcl-xL and Bcl-2
分子伴侣介导的 Bcl-xL 和 Bcl-2 蛋白质降解
- 批准号:
10599452 - 财政年份:2020
- 资助金额:
$ 17.74万 - 项目类别:
Inhibition of Bcl-xL by Targeted Degradation
通过靶向降解抑制 Bcl-xL
- 批准号:
10378075 - 财政年份:2020
- 资助金额:
$ 17.74万 - 项目类别:
Inhibition of Bcl-xL by Targeted Degradation
通过靶向降解抑制 Bcl-xL
- 批准号:
10133018 - 财政年份:2020
- 资助金额:
$ 17.74万 - 项目类别:
Inhibition of Bcl-xL by Targeted Degradation
通过靶向降解抑制 Bcl-xL
- 批准号:
10644990 - 财政年份:2020
- 资助金额:
$ 17.74万 - 项目类别:
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
使用 BCL-2 抑制剂 Venetoclax 和优化的 10 天地西他滨方案靶向高危 AML 和 MDS 中的细胞凋亡
- 批准号:
10415997 - 财政年份:2019
- 资助金额:
$ 17.74万 - 项目类别:
Targeting apoptosis in high-risk AML and MDS with BCL-2 inhibitor Venetoclax and optimized 10-day Decitabine regimen
使用 BCL-2 抑制剂 Venetoclax 和优化的 10 天地西他滨方案靶向高危 AML 和 MDS 中的细胞凋亡
- 批准号:
10654631 - 财政年份:2019
- 资助金额:
$ 17.74万 - 项目类别:
Targeting mitochondrial complex I in acute lymphoblastic leukemia
靶向急性淋巴细胞白血病中的线粒体复合物 I
- 批准号:
9815737 - 财政年份:2019
- 资助金额:
$ 17.74万 - 项目类别:
相似海外基金
EAGER: Toward a Decentralized Cross-administrator Zone Management System: Policy and Technology
EAGER:走向去中心化的跨管理员区域管理系统:政策和技术
- 批准号:
2331936 - 财政年份:2023
- 资助金额:
$ 17.74万 - 项目类别:
Standard Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
- 批准号:
2043230 - 财政年份:2021
- 资助金额:
$ 17.74万 - 项目类别:
Continuing Grant
COLLABORATIVE RESEARCH: Social Influence in Eyewitness Identification Procedures: Do Blind Administrator Behaviors Magnify the Effects of Suspect Bias?
合作研究:目击者识别程序中的社会影响:盲目的管理员行为是否会放大嫌疑人偏见的影响?
- 批准号:
2043334 - 财政年份:2021
- 资助金额:
$ 17.74万 - 项目类别:
Continuing Grant
Making of the base for patient safety management skill of visiting nurse administrator by the web conference system
利用网络会议系统构建出诊护士管理者患者安全管理技能基础
- 批准号:
19K10768 - 财政年份:2019
- 资助金额:
$ 17.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of the nursing administrator training program to improve leadership behavior focused on emotional intelligence
制定护理管理人员培训计划,以改善以情商为重点的领导行为
- 批准号:
18K17464 - 财政年份:2018
- 资助金额:
$ 17.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Automated Network Management that Dynamically Reflects Administrator Intent
动态反映管理员意图的自动化网络管理
- 批准号:
18K18038 - 财政年份:2018
- 资助金额:
$ 17.74万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Administrator support perceived as useful for professional growth by novice psychiatric home-visit nursing staff
新手精神科家访护理人员认为管理员支持对专业成长有用
- 批准号:
17H07005 - 财政年份:2017
- 资助金额:
$ 17.74万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
The Facts and Problems on Management of Public Museums: Validation of Designated Administrator System
公共博物馆管理的事实与问题:指定管理员制度的验证
- 批准号:
17K01212 - 财政年份:2017
- 资助金额:
$ 17.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Study on Transformation of the School Administrator Preparation and Evaluation System in the United States
美国学校管理人员培养与评价体系转型研究
- 批准号:
26780449 - 财政年份:2014
- 资助金额:
$ 17.74万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The Family Court's Supervision of Property Administrator
家庭法院对财产管理人的监督
- 批准号:
26380108 - 财政年份:2014
- 资助金额:
$ 17.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




